Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
17 July 2023
Closing Date:
18 August 2023
Location(s):
PL72 Świętokrzyskie (PL Poland/POLSKA)
Description:
Delivery of the drug UPADACITINIBUM 15mg x 28 tabl. Part 1- of Annex 1a; delivery of Guselkumabum Part 2- of Annex 1a; delivery of Epoetinum alfa part 3 - according to Annex 1a.

Delivery of the drug UPADACITINIBUM 15mg x 28 tabl. Part 1; supply of Guselkumabum part 2; delivery of Epoetinum alfa part 3

Delivery of the drug UPADACITINIBUM 15mg x 28 tabl.

Delivery of the drug UPADACITINIBUM 15mg x 28 tabl. with prolonged release to the drug program B.35 as described and quantified in Annex 1a

Delivery of Guselkumabum prefilled syringes and pens containing 100mg/1ml

Delivery of Guselkumabum prefilled syringes and pens containing 100mg/1ml to the B.35 drug programme as described and in Annex 1a

Delivery of the drug Epoetinum alfa solution. to injections. in amp. teat.

Delivery of the drug Epoetinum alfa solution. to injections. in amp. teat. according to the description and quantity in Annex 1a

Download full details as .pdf
The Buyer:
Zespół Opieki Zdrowotnej w Końskich
CPV Code(s):
33600000 - Pharmaceutical products